Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.750
+0.160 (3.49%)
At close: Dec 5, 2025, 4:00 PM EST
4.760
+0.010 (0.21%)
After-hours: Dec 5, 2025, 4:10 PM EST
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of $40.57 million as of December 5, 2025. Its market cap has increased by 10.28% in one year.
Market Cap
40.57M
Enterprise Value
19.99M
1-Year Change
10.28%
Ranking
Category
Stock Price
$4.75
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from $72.85M to $40.57M, a decrease of -44.31%. That is a compound annual growth rate of -13.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 40.57M | 24.52% |
| Dec 31, 2024 | 32.58M | 73.79% |
| Dec 29, 2023 | 18.75M | -20.04% |
| Dec 30, 2022 | 23.45M | -67.78% |
| Dec 31, 2021 | 72.76M | -0.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 903.36B |
| Johnson & Johnson | 486.20B |
| AbbVie | 399.73B |
| UnitedHealth Group | 299.15B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.52B |
| Abbott Laboratories | 217.39B |